Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Benjamin Franc

Thyroid and Hepatic Function After High-Dose 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy for Neuroblastoma

Pediatric Blood and Cancer

English

Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study

Journal of Clinical Oncology

English

Related publications

Toxicity of Upfront 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy in Newly Diagnosed Neuroblastoma Patients: A Retrospective Analysis

European Journal of Nuclear Medicine and Molecular Imaging

English

Experiences From Introducing Standardized High Dose 131i-mIBG Treatment of Children With Refractory Neuroblastoma: Differences in Effective Dose to Patients and Exposure to Caregivers

Journal of Nuclear Medicine & Radiation Therapy

2015

English

Effects and Safety of 131i-Metaiodobenzylguanidine (MIBG) Radiotherapy in Malignant Neuroendocrine Tumors: Results From a Multicenter Observational Registry

English

Prognostic Values of Initial Responses to Low-Dose 131i-Mibg Therapy in Patients With Malignant Pheochromocytoma and Paraganglioma

Annals of Nuclear Medicine

English

Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma

JAMA - Journal of the American Medical Association

Medicine

2000

English

Hypothyroidism and 131I Therapy

BMJ

1968

English

Gene Expression Signature in Mouse Thyroid Tissue After 131I and 211At Exposure

English

Rat Sodium Iodide Symporter Allows Using Lower Dose of 131I for Cancer Therapy

English

Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma

Frontiers in Oncology

Cancer Research

Oncology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Benjamin Franc

Thyroid and Hepatic Function After High-Dose 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy for Neuroblastoma

Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study

Related publications

Toxicity of Upfront 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy in Newly Diagnosed Neuroblastoma Patients: A Retrospective Analysis

Experiences From Introducing Standardized High Dose 131i-mIBG Treatment of Children With Refractory Neuroblastoma: Differences in Effective Dose to Patients and Exposure to Caregivers

Effects and Safety of 131i-Metaiodobenzylguanidine (MIBG) Radiotherapy in Malignant Neuroendocrine Tumors: Results From a Multicenter Observational Registry

Prognostic Values of Initial Responses to Low-Dose 131i-Mibg Therapy in Patients With Malignant Pheochromocytoma and Paraganglioma

Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma

Hypothyroidism and 131I Therapy

Gene Expression Signature in Mouse Thyroid Tissue After 131I and 211At Exposure

Rat Sodium Iodide Symporter Allows Using Lower Dose of 131I for Cancer Therapy

Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma